cis-Dichlorodiammineplatinum (II) and hexamethylmelamine in advanced ovarian carcinoma: a phase II study.

[1]  P. Schwartz,et al.  Epithelial carcinoma of the ovary: current strategies. , 1981, Annals of internal medicine.

[2]  C. Griffiths,et al.  cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer. , 1980, Cancer treatment reports.

[3]  L. Lagasse,et al.  cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group. , 1979, Cancer treatment reports.

[4]  R. Makuch,et al.  cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer. , 1979, Cancer treatment reports.

[5]  E. Wiltshaw,et al.  Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital. , 1979, Cancer treatment reports.

[6]  C. Belloni,et al.  Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycin. , 1979, Cancer treatment reports.

[7]  R. Fisher,et al.  Hexamethylmelamine in alkylating agent‐resistant ovarian carcinoma , 1978, Cancer.

[8]  R. Young,et al.  Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy. , 1978, Cancer treatment reports.

[9]  C. Cohen,et al.  Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy. , 1978, Cancer treatment reports.

[10]  M. Piver,et al.  cis-Dichlorodiammineplatinum(II) as third-line chemotherapy in advanced ovarian adenocarcinoma. , 1978, Cancer treatment reports.

[11]  J. Smith,et al.  Second trial drugs in ovarian cancer. , 1977, Gynecologic oncology.

[12]  M. Piver,et al.  Weekly cis-diamminedichloroplatinum(II): active third-line chemotherapy in ovarian carcinoma--a preliminary report. , 1980, Cancer treatment reports.

[13]  G. Wilbanks,et al.  Phase II trial of hexamethylmelamine in ovarian carcinoma resistant to alkylating agents. , 1979, Cancer treatment reports.